Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Aug 9, 2018 8-K
10-Q Aug 9, 2018 10-Q
4 Jul 17, 2018 OWNERSHIP DOCUMENT
SC 13D/A Jul 17, 2018
8-K Jul 17, 2018 8-K
8-K Jul 16, 2018 8-K
424B4 Jul 13, 2018 424B4
EFFECT Jul 12, 2018
S-1/A Jul 11, 2018 S-1/A
8-K Jul 9, 2018 8-K
S-1 Jul 9, 2018 S-1
8-K Jul 9, 2018 8-K
4 Jul 6, 2018 FORM 4 SUBMISSION
4 Jul 6, 2018 FORM 4 SUBMISSION
4 Jul 6, 2018 FORM 4 SUBMISSION
8-K Jun 8, 2018 FORM 8-K
4 Jun 6, 2018 FORM 4 SUBMISSION
4 Jun 6, 2018 FORM 4 SUBMISSION
4 Jun 6, 2018 FORM 4 SUBMISSION
4 Jun 6, 2018 FORM 4 SUBMISSION
4 Jun 6, 2018 FORM 4 SUBMISSION
4 Jun 6, 2018 FORM 4 SUBMISSION
DRS May 25, 2018
8-K May 10, 2018 8-K
10-Q May 10, 2018 SPERO THERAPEUTICS, INC. Q1 2018 10-Q
← Newer Page 18 of 21 · 513 filings Older →